Suppr超能文献

细胞坏死性凋亡及其在炎症性肠病治疗靶点的作用

The Function of Necroptosis and Its Treatment Target in IBD.

机构信息

Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province Department of Laboratory Medicine School of Medicine Jiangsu University, Zhenjiang 212013, Jiangsu, China.

The People's Hospital of Danyang Affiliated Danyang Hospital of Nantong University, Zhenjiang 212300, Jiangsu, China.

出版信息

Mediators Inflamm. 2024 Jul 31;2024:7275309. doi: 10.1155/2024/7275309. eCollection 2024.

Abstract

Inflammatory bowel disease (IBD), which encompasses Crohn's disease (CD) and ulcerative colitis (UC), is a complicated illness whose exact cause is yet unknown. Necroptosis is associated with IBD pathogenesis, leading to intestinal barrier abnormalities and uncontrolled inflammation. Molecules involved in necroptosis, however, exhibit different expression levels in IBD and its associated colorectal cancer. Multiple studies have shown that inhibiting these molecules alleviates necroptosis-induced IBD. Moreover, due to the severe scarcity of clinical medications for treating IBD caused by necroptosis, we review the various functions of crucial necroptosis molecules in IBD, the stimuli regulating necroptosis, and the current emerging therapeutic strategies for treating IBD-associated necroptosis. Eventually, understanding the pathogenesis of necroptosis in IBD will enable the development of additional therapeutic approaches for the illness.

摘要

炎症性肠病(IBD)包括克罗恩病(CD)和溃疡性结肠炎(UC),是一种复杂的疾病,其确切病因尚不清楚。细胞坏死性凋亡与 IBD 的发病机制有关,导致肠道屏障异常和失控性炎症。然而,参与细胞坏死性凋亡的分子在 IBD 及其相关结直肠癌中的表达水平不同。多项研究表明,抑制这些分子可减轻细胞坏死性凋亡诱导的 IBD。此外,由于治疗由细胞坏死性凋亡引起的 IBD 的临床药物严重缺乏,我们综述了关键细胞坏死性凋亡分子在 IBD 中的各种功能、调节细胞坏死性凋亡的刺激因素以及治疗与细胞坏死性凋亡相关的 IBD 的新兴治疗策略。最终,了解细胞坏死性凋亡在 IBD 中的发病机制将为该疾病的治疗方法的发展提供更多的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d3/11306684/0723e401affb/MI2024-7275309.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验